Wednesday, June 10, 2026
πŸ‡ΊπŸ‡Έ FDA

pharma Β· Diabetic Macular Edema Β· Hypercholesterolemia Β· REGN

Regeneron UK

Regeneron UK Limited

Regeneron UK clinical programs β€” 493 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

Website Investor relations
Tarrytown, USA HQ
16,715 Employees
Public company Type
REGN Β· NYSE Ticker
Company details
Status
Public
HQ
Tarrytown, USA
Employees
16,715
Programs
493
Drugs
98
Patents
837
Official website β†— All projects Drug pipeline Patents News & analysis

Recent coverage

View all news & analysis β†’
Intelligence Β· Clinical Programs

Regeneron UK projects

493 ClinicalTrials.gov programs sponsored by Regeneron UK.

Regeneron UK has 493 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

All phases Phase III Phase II Phase I NDA / BLA filed Approved programs

493 programs

Clinical programs

Page 7 of 11

  1. Vonsetamig

    Regeneron UK Limited

    Chronic Kidney Disease (CKD)

    phase 2 small molecule active

    1 trial

  2. ZIV-Aflibercept

    Regeneron UK Limited

    Metastatic Uveal Melanoma

    phase 2 small molecule active

    1 trial

  3. Ziv-Aflibercept

    Regeneron UK Limited

    Uveal Melanoma

    phase 2 mab terminated

    1 trial

  4. aflibercept

    Regeneron UK Limited

    Neovascular (Wet) Age-Related Macular Degeneration

    phase 2 small molecule completed

    1 trial

  5. aflibercept + FOLFIRI

    Regeneron UK Limited

    Metastatic Colorectal Cancer

    phase 2 small molecule terminated

    1 trial

  6. casirivimab+imdevimab

    Regeneron UK Limited

    COVID-19

    phase 2 small molecule terminated

    2 trials

  7. casirivimab+imdevimab

    Regeneron UK Limited

    Healthy

    phase 2 small molecule completed

    2 trials

  8. cemiplimab

    Regeneron UK Limited

    Advanced Cutaneous Squamous Cell Carcinoma

    phase 2 small molecule completed

    1 trial

  9. cemiplimab

    Regeneron UK Limited

    Carcinoma, Basal Cell

    phase 2 small molecule completed

    1 trial

  10. cemiplimab

    Regeneron UK Limited

    Cutaneous Basal Cell Carcinoma

    phase 2 small molecule active

    1 trial

  11. cemiplimab

    Regeneron UK Limited

    Melanoma

    phase 2 small molecule active

    1 trial

  12. cemiplimab (monotherapy)

    Regeneron UK Limited

    Relapsed Solid Tumor

    phase 2 small molecule terminated

    1 trial

  13. dupilumab

    Regeneron UK Limited

    Chronic Sinusitis

    phase 2 mab completed

    1 trial

  14. dupilumab

    Regeneron UK Limited

    Allergic Bronchopulmonary Aspergillosis

    phase 2 small molecule completed

    1 trial

  15. evinacumab

    Regeneron UK Limited

    Severe Hypertriglyceridemia (sHTG)

    phase 2 small molecule completed

    1 trial

  16. evinacumab

    Regeneron UK Limited

    Hypertriglyceridemia

    phase 2 small molecule terminated

    1 trial

  17. vidutolimod

    Regeneron UK Limited

    Merkel Cell Carcinoma

    phase 2 small molecule terminated

    1 trial

  18. 89ZrΛ—DFOΛ—REGN3504

    Regeneron UK Limited

    Advanced PD-L1 Positive Malignancies

    phase 1 small molecule terminated

    1 trial

  19. 89ZrΛ—DFOΛ—REGN5054

    Regeneron UK Limited

    Advanced Solid Tumor

    phase 1 small molecule active

    1 trial

  20. ALN-ANG3

    Regeneron UK Limited

    Healthy Volunteers With Hyperlipidemia

    phase 1 small molecule active

    1 trial

  21. ALN-APOC3

    Regeneron UK Limited

    Dyslipidemia

    phase 1 small molecule completed

    1 trial

  22. ALN-F1202

    Regeneron UK Limited

    Healthy Volunteer

    phase 1 small molecule active

    1 trial

  23. ALN-PNP

    Regeneron UK Limited

    Nonalcoholic Fatty Liver Disease (NAFLD)

    phase 1 small molecule completed

    1 trial

  24. ALN-SNCA

    Regeneron UK Limited

    Parkinsons Disease

    phase 1 small molecule active

    1 trial

  25. ASP8374

    Regeneron UK Limited

    Glioblastoma

    phase 1 small molecule completed

    1 trial

  26. AVE0005 (aflibercept)

    Regeneron UK Limited

    Colorectal Neoplasms

    phase 1 small molecule completed

    1 trial

  27. Aflibercept

    Regeneron UK Limited

    Neovascular Macular Degeneration

    phase 1 small molecule completed

    1 trial

  28. Aflibercept

    Regeneron UK Limited

    Irvine-Gass Syndrome

    phase 1 small molecule terminated

    1 trial

  29. Aflibercept (AVE0005)

    Regeneron UK Limited

    Neoplasm Malignant

    phase 1 small molecule completed

    2 trials

  30. Aflibercept every 2 months

    Regeneron UK Limited

    Radiation Retinopathy

    phase 1 small molecule completed

    1 trial

  31. Alirocumab

    Regeneron UK Limited

    Stroke

    phase 1 small molecule terminated

    1 trial

  32. Alirocumab

    Regeneron UK Limited

    Sepsis

    phase 1 small molecule completed

    1 trial

  33. Alirocumab (Solution)

    Regeneron UK Limited

    Hypercholesterolemia

    phase 1 small molecule completed

    1 trial

  34. Arm 1 cemiplimab

    Regeneron UK Limited

    Hepatocellular Carcinoma

    phase 1 small molecule active

    1 trial

  35. Aspirin

    Regeneron UK Limited

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  36. BPX-601

    Regeneron UK Limited

    Metastatic Castration-resistant Prostate Cancer

    phase 1 mab terminated

    1 trial

  37. BPX-601

    Regeneron UK Limited

    Prostate Cancer

    phase 1 gene therapy active

    1 trial

  38. CMP-001

    Regeneron UK Limited

    Non Small Cell Lung Cancer

    phase 1 small molecule completed

    1 trial

  39. CMP-001

    Regeneron UK Limited

    Malignant Melanoma

    phase 1 small molecule completed

    1 trial

  40. Casirivimab and Imdevimab Antibody Cocktail

    Regeneron UK Limited

    COVID-19

    phase 1 small molecule terminated

    1 trial

  41. Cemiplimab

    Regeneron UK Limited

    Locally Advanced Head and Neck Squamous Cell Carcinoma

    phase 1 small molecule active

    1 trial

  42. Cemiplimab

    Regeneron UK Limited

    Epithelial Ovarian Cancer

    phase 1 small molecule active

    1 trial

  43. Cemiplimab

    Regeneron UK Limited

    Lung Cancer

    phase 1 small molecule active

    1 trial

  44. Cemiplimab

    Regeneron UK Limited

    Anaplastic Thyroid Cancer

    phase 1 mab active

    1 trial

  45. Cemiplimab

    Regeneron UK Limited

    Advanced Malignancies

    phase 1 small molecule active

    1 trial

  46. Cemiplimab

    Regeneron UK Limited

    Hormone Receptor-positive Breast Cancer

    phase 1 small molecule completed

    1 trial

  47. Cemiplimab

    Regeneron UK Limited

    Advanced Cancer

    phase 1 small molecule completed

    1 trial

  48. Cemiplimab-Rwlc

    Regeneron UK Limited

    Merkel Cell Carcinoma

    phase 1 small molecule active

    1 trial

Frequently asked questions

How many clinical projects does Regeneron UK have?

493 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.

Drug approvals, clinical trials, M&A, event intelligence, and company updates β€” weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.